NCT04102046 is a clinical trial in Hemophilia Arthropathy, sponsored by Assiut University.

Who is sponsoring NCT04102046?

NCT04102046 is sponsored by Assiut University.

What condition does NCT04102046 study?

NCT04102046 studies Hemophilia Arthropathy.

Is NCT04102046 still recruiting?

NCT04102046 is currently status unknown. Last updated 28 January 2020.

Last reviewed 2020-01-28 · How we verify

NCT04102046

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Life in Hemophilia by Clinical Scoring System (FISH)Score

Status unknown Last updated 28 January 2020

What this trial tests

trial in Hemophilia Arthropathy in 45 participants. Status unknown.

Timeline

28 June 2020

Primary endpoint
22 September 2020

10 October 2020

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	45
Start date	28 June 2020
Primary completion	22 September 2020
Estimated completion	10 October 2020

Conditions studied

Hemophilia Arthropathy — all drugs for Hemophilia Arthropathy →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Hemophilia Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To asses quality of life in patients with hemophilia clinically.- -To avoid or minimize structural damage to goints and muscles by making patients aware of importance of rehabilitation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

ABSTRACT NUMBER: ESOC2026A2364 BALLOON GUIDE CATHETER USE IS ASSOCIATED WITH IMPROVED CLINICAL AND ANGIOGRAPHIC OUTCOMES IN MECHANICAL THROMBECTOMY: A POST-HOC ANALYSIS OF THE PROST RANDOMIZED TRIAL
· 2026

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04102046 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 28 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04102046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing